In this context it is important to note that, though not all glioblastoma patients are resistant to anti-VEGF therapy, the possibility of angiogenesis-independent tumor progression by diffuse invasion of single tumor cell in brain, as reported recently [66]. This evidence concerns the gene VEGFA and glioblastoma.